Better Birth Outcomes Through Technology, Education, and Reporting
This study, called BETTER, is testing if a special program can help reduce problems during pregnancy like maternal anemia (low red blood cell count) and other issues. The program involves motivational interviewing (a type of counseling) and text messages. These messages connect you to your care team and resources for social needs like housing, food, or transportation. We want to see if this program works better than standard care. You might be able to join if you are at least 18 years old, less than 20 weeks and 6 days pregnant, have a single pregnancy with a heartbeat, speak English, can receive text messages, and get your obstetric care at OSU McCampbell Hall or OSU Outpatient Care East. The main goal is to see if the BETTER program reduces maternal anemia by the time of delivery. The study is currently unclear on its recruitment status.
- Study design
- This is a pragmatic randomized control trial, meaning participants are randomly assigned to either the BETTER program or standard care. It plans to include about 550 pregnant individuals.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome, incidence of maternal anemia, is measured at delivery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Better Birth Outcomes Through Technology, Education, and Reporting
At a glance
Conditions
Where it's being run
3 sites across 1 statesStudy leadership
- William Grobman, MD, MBA · PRINCIPAL_INVESTIGATOR · Ohio State University
- Ann McAlearney, ScD, MS · PRINCIPAL_INVESTIGATOR · Ohio State University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Incidence of maternal anemiaAt delivery
Hemoglobin \< 11.0 g/dL